As far as we know, this is the first study in which serum levels of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), inflammatory markers (ESR CRP and fibrinogen), and tumor markers (CEA and CA 19.9) have been compared in colorectal cancer. The gene discussed is CEACAM5; the disease is neoplasm.